TESAMORELIN

Summary

Tesamorelin is one of the most robust research peptides in the growth hormone axis: it is studied for its role in visceral fat, metabolism, and body composition. Technically, it is a synthetic analog of 44-amino acid GHRH, stabilized with a trans-3-hexenoyl group, and is one of the GHRH analogs with the most clinical support, with regulatory approval for the reduction of visceral fat.

What is it being researched for?

• •  Reduction of visceral fat
• •  Physiological stimulation of growth hormone
• •  Body composition and muscle density
• •  Lipid profile and metabolic markers

Cycle and Rest

Mechanism of action

Physiological stimulation of growth hormone

It acts on the GHRH receptor, preserving the pulsatile release of growth hormone and the hepatic production of IGF-1, without altering its natural pattern.

Reduction of visceral fat

Its most studied application is the reduction of visceral adipose tissue, with improvement in lipid profile and metabolic markers.

Metabolism and body composition

Its effect on mitochondrial biogenesis, fatty acid β-oxidation, and the AMPK and PI3K/AKT/mTOR pathways is being investigated.

Scientific evidence

Stability: its chemical modification gives it greater stability than native GHRH, prolonging its action.

Visceral fat: clinical trials describe significant reductions in visceral fat; it is the only GHRH analog with approval for this indication (HIV-associated lipodystrophy).

Body composition: clinical programs support improvements in body composition and metabolic function.

Product Use

With clinical approval for visceral fat reduction, Tesamorelin is a top-tier reference material in research on the somatotropic axis and metabolism. At Peptido BioGenetic, we offer it as a high-purity peptide for laboratory use, with a certificate of analysis (COA) available upon request.

⚠️ Product exclusively for research and laboratory use. Not suitable for human or veterinary consumption.